Mode
Text Size
Log in / Sign up
N/A Completed N=10 Treatment

Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study

Source: ClinicalTrials.gov NCT02081573 ↗
Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Mar 2018
Primary outcomePrimary: Acceptability Questionnaire. — 2.49 mean of scale items

Summary

Primary aim: examine feasibility and acceptability of a brief cognitive therapy protocol for type II diabetes administered by nurse care managers or health coaches via phone.

Outcome Measures

OutcomeResultp-value
PRIMARY
Acceptability Questionnaire.
2.49
SECONDARY
Morisky Questionnaire
.10
SECONDARY
Diabetes Distress Scale
-.77
SECONDARY
Medication Beliefs Scale
SECONDARY
HbA1c Level
-.22
SECONDARY
Body Mass Index
-1.22

Eligibility Criteria

Inclusion Criteria

Ten adults will be recruited through the UPMC health plan and are treated at a primary care center. To be considered for inclusion subjects must:

  • have a diagnosis of T2DM;
  • have a score of >3 on the Diabetes Distress Scale;
  • be taking at least one oral antihyperglycemic agent (the patient may also be using injectable antihyperglycemic medications, including insulin);
  • have an HbA1c level of greater than 8 at baseline;
  • be receiving treatment for T2DM in the primary care setting;
  • be aged 30 - 65 years and
  • be able to read at the 8th-grade level and to provide informed consent.

Four nurse care managers will also be recruited from UPMC Health Care. To be considered they must be employed at UPMC Health Care and

  • Have received the Brief CBT Training that was given in Phase I of this study;
  • Be identified as a RN or a RN who is a diabetes nurse educator; and have Nurse Care Management responsibilities with patients who have Type 2 Diabetes.

Nurses will be excluded from the study if:

  • They did not successfully complete the training in Phase I or
  • Are not Nurse Care Managers at UPMC Health Care. -

Exclusion Criteria

The following are exclusion criteria:

  • major psychiatric disorder and suicidal risk;
  • dementia or disorders with substantial cognitive impairment. -
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02081573). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search